Most Read Articles
Pearl Toh, Yesterday
First-line therapy with the BTK* inhibitor ibrutinib plus the anti-CD20 immunotherapy rituximab confers significant survival advantage over the current gold-standard regimen of fludarabine, cyclophosphamide, and rituximab (FCR) for young, fit patients with treatment-naïve chronic lymphocytic leukaemia (CLL), according to the E1912 trial, a large cooperative group study supported by the US National Cancer Institute.
6 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
4 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 6 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.

Extremely premature birth negatively influences visual outcomes in early adult life

15 Sep 2018

Young adults born extremely preterm (EP) exhibit considerable structural alterations at the fovea, a study has shown. Increased ganglion cell layer thickness is associated with poor best-corrected visual acuity (BVCA), with retinal layer thickness and BCVA being profoundly affected in eyes requiring neonatal treatment for retinopathy of prematurity (ROP).

Researchers followed 177 young adults (354 eyes; 226 from former EP infants and 128 from age-matched full-term controls) for 19 years to quantify inner and outer retinal layer thicknesses in relation to visual function.

In the EP group, 50 percent of eyes were not previously diagnosed with neonatal ROP, 38 percent had ROP not requiring treatment in the neonatal period, and 13 percent had neonatal cryotherapy or laser ablation for ROP.

Compared with control eyes, EP eyes showed significantly thicker inner and outer retinal layers and reduced BCVA. Retinal layer thicknesses and BCVA did not differ between eyes with untreated ROP and those without neonatal ROP. On the other hand, eyes with treated ROP had greater inner and outer retinal layer thickness and decreased vision.

Worse BCVA correlated with inner retinal layer thickness (p<0.001) but not outer retinal layer thickness (p=0.80). In multivariate linear regression models, ganglion cell layer thickness was a significant independent predictor of BCVA.

The present data provide insight into the pathophysiologic mechanisms after preterm birth that are involved in the maturation of the human fovea, researchers said.

Longitudinal studies are needed to examine changes in the retinal layers and visual acuity over time, as well as determine the postnatal age at which the increase in retinal ganglion layer thickness stops. This information would be important for future clinical trials using age-specific retinal thickness profiles as endpoints to predict visual acuity changes in ROP.

Editor's Recommendations
Most Read Articles
Pearl Toh, Yesterday
First-line therapy with the BTK* inhibitor ibrutinib plus the anti-CD20 immunotherapy rituximab confers significant survival advantage over the current gold-standard regimen of fludarabine, cyclophosphamide, and rituximab (FCR) for young, fit patients with treatment-naïve chronic lymphocytic leukaemia (CLL), according to the E1912 trial, a large cooperative group study supported by the US National Cancer Institute.
6 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
4 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 6 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.